- XV Eurasian Hematology-Oncology Congress - EHOC 2024
- XIV Eurasian Hematology-Oncology Congress - EHOC 2023
- 8th Eurasian Hematology Oncology Summit
- XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- 7th Eurasian Hematology Oncology Summit
- Xth Eurasian Hematology-Oncology Congress
- Events
Playback speed
10 seconds
Analysis of PFS in CLL: Pts Who Received First-Line Bendamustine-Rituximab Depending on The Elimination Rate of The MRD and IGHV
0 views
March 30, 2020
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology